Tenecteplase Compared to Alteplase for Patients With Large Vesel Oclusion Suspicion Before Thrombectomy
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 500 participants.
Also called NCT05626972
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 500 participants
- Registry
-
NCT05626972
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Spain
- Registry status
- Unknown status
Technical summary
Registry record NCT05626972. Randomized; single masking; primary purpose treatment. Start 2022-05-27 (actual); primary completion 2023-05 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Tenecteplase Compared to Alteplase for Patients With Large Vesel Oclusion Suspicion Before Thrombectomy
- Condition
- Acute Ischemic Stroke
- Intervention (Drug)
- Tenecteplase
- Lead sponsor
- Hospital Universitari Vall d'Hebron Research Institute
- Collaborator
- Instituto de Salud Carlos III
Record details
- Record id
cardio:ct-nct05626972- Content hash
01d3d76faf335987710225ad8aa258dbf13b74c603eb40ba4d4e501a2f4935e2